BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 7529112)

  • 1. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
    Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK
    Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Mallard N; Marshall R; Sithers A; Spriggs B
    Eur J Pharmacol; 1992 Sep; 220(1):1-10. PubMed ID: 1330614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-induced facilitation of sympathetic neurotransmission to the rat vas deferens: effects of suramin.
    Lau WA; Ventura S; Jiang Q; Pennefather JN
    Eur J Pharmacol; 1995 Jan; 272(1):31-8. PubMed ID: 7536159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypophysectomy on purinergic and noradrenergic contractility of the rat vas deferens.
    Ralevic V; Burnstock G
    J Auton Pharmacol; 1996 Aug; 16(4):191-6. PubMed ID: 8953373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
    Bailey SJ; Hourani SM
    Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of AMP-induced inhibition of sympathetic neurotransmission in the isolated vas deferens of the rat and guinea-pig.
    Dalziel HH; Sneddon P
    Br J Pharmacol; 1988 Jul; 94(3):961-7. PubMed ID: 2846112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against nitrergic neuromodulation in the rat vas deferens.
    Ventura S; Burnstock G
    Eur J Pharmacol; 1997 Sep; 334(1):87-93. PubMed ID: 9346332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of lumbar sympathetic nerves evokes contractions of cat colon circular muscle mediated by ATP and noradrenaline.
    Venkova K; Krier J
    Br J Pharmacol; 1993 Nov; 110(3):1260-70. PubMed ID: 7905343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for participation of nitric oxide in excitatory neurotransmission in rat vas deferens.
    Vladimirova I; Jurkiewicz NH; Jurkiewicz A
    Life Sci; 1994; 55(14):1123-8. PubMed ID: 8090053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthesis reveals non-cholinergic excitatory neurotransmission in the canine proximal colon.
    Shuttleworth CW; Sanders KM; Keef KD
    Br J Pharmacol; 1993 Jul; 109(3):739-47. PubMed ID: 7689401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
    Bültmann R; Kurz AK; Starke K
    Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272.
    da Silva FH; Claudino MA; Báu FR; Rojas-Moscoso JA; Mónica FZ; De Nucci G; Antunes E
    Eur J Pharmacol; 2012 Aug; 688(1-3):49-55. PubMed ID: 22634166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractility of urinary bladder and vas deferens after sensory denervation by capsaicin treatment of newborn rats.
    Ziganshin AU; Ralevic V; Burnstock G
    Br J Pharmacol; 1995 Jan; 114(1):166-70. PubMed ID: 7712013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide modulates biphasic contractile response of guinea pig vas deferens to electrical field stimulation.
    Nakanishi H; Matsuoka I; Nakahata N
    Fukushima J Med Sci; 2006 Dec; 52(2):45-57. PubMed ID: 17427755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prejunctionally mediated inhibition of neurotransmission by isoprenaline in rat vas deferens.
    Huang Y; Lau CW; Chan NW; Yao XQ; Chan FL
    Life Sci; 1998; 63(23):2107-13. PubMed ID: 9839534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.
    Gur S; Sikka SC; Knight GE; Burnstock G; Hellstrom WJ
    Asian J Androl; 2010 May; 12(3):415-21. PubMed ID: 20305675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridine.
    Kaschube M; Zetler G
    J Neural Transm; 1989; 76(1):39-53. PubMed ID: 2540260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
    Amobi NI; Chung IP; Smith IC
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.
    Qian YM; Jones RL
    Br J Pharmacol; 1995 May; 115(1):163-71. PubMed ID: 7544196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.